Henry Hadad’s Statement to Senate IP Subcommittee on IP re: Patent Subject Matter Eligibility
Henry Hadad's Statement to Senate IP Subcommittee on IP re: [...]
Henry Hadad's Statement to Senate IP Subcommittee on IP re: [...]
Joint Submission by IPO and Others to Secretariat of Convention [...]
IPO Amicus Brief in Acorda Therapeutics v. Roxane Labs., et. [...]
IPO Comments to China National Intellectual Property Administration on Draft [...]
IPO Comments re: Additional Discussion of TTAB Standard Protective Order
IPO Comments to USPTO Re: U.S. Counsel Requirement for Foreign [...]
IPO Comments on Updated USPTO Section 112 Guidance
IPO Comments on USPTO Revised Section 101 Guidance
IPO Comments on the Foreign Investment Law of the People’s [...]
IPO Comments to EPO On 2019-2023 Strategic Plan